Newly diagnosed multiple myeloma: making sense of the menu.

ABSTRACT: The development of new drugs and subsequent novel combinations for the treatment of newly diagnosed multiple myeloma (NDMM) has resulted in a plethora of treatment options that can make the choice of initial induction therapy a challenge. A greater understanding of both patient- and disease-specific factors can provide a personalized approach to help design a treatment course. Historically, the choice of an induction regimen has been tethered to an initial impression of transplant eligibility at the time of diagnosis. As more effective and better-tolerated induction regimens have emerged, there has been increasing overlap in the induction strategies used for all patients with NDMM, which increasingly provide the ultimate goal of deep and durable remissions. The current treatment options an

SUBMITTER: Costello CL 

PROVIDER: S-EPMC9820388 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature